Research Summary

As Director of the Global Cancer Program at the UCSF Helen Diller Family Comprehensive Cancer Center, I oversee UCSF’s portfolio of research and capacity-building projects in low and middle-income countries as well as educational programs for training in global oncology. My research interest focuses on the epidemiology of gastrointestinal cancers both in the United States and globally, with the aim to improve clinical outcomes and reduce disparities. In collaboration with Muhimbili University of Health and Allied Sciences and Ocean Road Cancer Institute in Tanzania, I am the Principal Investigator of studies to evaluate the etiology of the disproportionately high burden of esophageal squamous cell carcinoma in East Africa. I am the Principal Investigator of a D43 award that is building the first-ever cancer research training program in Tanzania. I am also actively engaged in research on the increasing burden of early-onset colorectal cancer in the United States and the disproportionate impact of this disease on black and Latinx communities. I have partnered with the Instituto Nacional de Cancerología (National Cancer Institute) and Instituto Nacional de Salud Pública (National Institute of Public Health) in Mexico to develop a collaborative research program to evaluate the changing epidemiology of colorectal cancer in Mexicans and Mexican-Americans. In all collaborations, I aim to support the career development of early career investigators with interests in global cancer control.

Education

Duke University    B.S.    05/00    Biology
Yale University    M.P.H.    05/02    Health Policy
Medical College of Georgia    M.D.    05/06    Medicine
Beth Israel Deaconess, Harvard Medical School    Intern    06/07    Internal Medicine
Beth Israel Deaconess, Harvard Medical School    Resident    06/09    Internal Medicine
University of California, San Francisco    Fellow    06/12    Oncology

Honors & Awards

  • 2018
    Hematology/Oncology Marc A. Shuman Mentoring Award, UCSF
  • 2017
    2017-2018 Short-Term Mentor Award, Pathways to Discovery, UCSF School of Medicine
  • 2016
    The Ernest H. Rosenbaum, MD Commitment to Patient Care Award, UCSF Helen Diller Family Comprehensive Cancer Center
  • 2013
    NANETS Clinical Investigator Scholarship
  • 2013
    AHRQ K12 PARTNERS Program Scholar
  • 2012
    Young Investigator Award, ASCO Conquer Cancer Foundation
  • 2008
    Yale/Johnson & Johnson Physician Scholar in International Health, South Africa
  • 2008
    Nomination by Harvard Medical School Class of 2008 for Excellence in Teaching
  • 2002
    Dean’s Prize for Outstanding MPH Thesis, Yale University
  • 2001
    Weinerman Fellowship for Social Justice, Yale University
  • 2000
    Graduation with Distinction in Biology, Duke University
  • 2000
    Howard Hughes Undergraduate Fellowship in Neuroscience, Duke University

Selected Publications

  1. Susko MS, Lazar AA, Wang CJ, Van Loon K, Feng M, Hope TA, Behr S, Anwar M Use of advanced PET-volume metrics predicts risk of local recurrence and overall survival in anal cancer.  View on PubMed
  2. Philipo GS, Vuhahula E, Kimambo A, Mmbaga EJ, Van Loon K, Ng DL Feasibility of Fine-Needle Aspiration Biopsy and Rapid On-Site Evaluation for Immediate Triage in Breast Cancer Screening in Tanzania.  View on PubMed
  3. Mushi BP, Mwachiro MM, Buckle G, Kaimila BN, Mulima G, Kayamba V, Kelly P, Akoko L, Mmbaga EJ, Selekwa M, Ringo Y, Pritchett N, White RE, Topazian MD, Fleischer DE, Dawsey SM, Van Loon K Improving Access to Self-Expanding Metal Stents for Patients With Esophageal Cancer in Eastern Africa: A Stepwise Implementation Strategy.  View on PubMed
  4. Blanchard C, Lubuzo B, Asirwa FC, Dlamini X, Msadabwe-Chikuni SC, Mwachiro M, Shyirambere C, Ruhangaza D, Milner DA, Van Loon K, DeBoer R, Mtshali P, Dugan U, Baker E, Shulman LN Multisector Collaborations and Global Oncology: The Only Way Forward.  View on PubMed
  5. Mmbaga EJ, Mushi BP, Deardorff K, Mgisha W, Akoko LO, Paciorek A, Hiatt RA, Buckle GC, Mwaiselage J, Zhang L, Van Loon K A Case-Control Study to Evaluate Environmental and Lifestyle Risk Factors for Esophageal Cancer in Tanzania.  View on PubMed
  6. Kimambo AH, Vuhahula EA, Mwakigonja AR, Ljung BM, Zhang L, Van Loon K, Ng DL Evaluating Estrogen Receptor Immunohistochemistry on Cell Blocks From Breast Cancer Patients in a Low-Resource Setting.  View on PubMed
  7. Buckle GC, Mahapatra R, Mwachiro M, Akoko L, Mmbaga EJ, White RE, Bent S, Van Loon K Optimal management of esophageal cancer in Africa: A systemic review of treatment strategies.  View on PubMed
  8. Van Blarigan EL, Zhang S, Ou FS, Venlo A, Ng K, Atreya C, Van Loon K, Niedzwiecki D, Giovannucci E, Wolfe EG, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA Association of Diet Quality With Survival Among People With Metastatic Colorectal Cancer in the Cancer and Leukemia B and Southwest Oncology Group 80405 Trial.  View on PubMed
  9. Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Hammer MJ, Kenfield SA, Kober KM, Levine JD, Pozzar R, Rhoads KF, Van Blarigan EL, Van Loon K Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic.  View on PubMed
  10. DeBoer RJ, Fadelu TA, Shulman LN, Van Loon K Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic.  View on PubMed
  11. Silverstein J, Post AL, Chien AJ, Olin R, Tsai KK, Ngo Z, Van Loon K Multidisciplinary Management of Cancer During Pregnancy.  View on PubMed
  12. Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Cooper BA, Hammer MJ, Kenfield SA, Laffan A, Levine JD, Pozzar R, Tsai KK, Van Blarigan EL, Van Loon K Oncology patients' perceptions of and experiences with COVID-19.  View on PubMed
  13. Enzinger AC, Uno H, McCleary N, Frank E, Sanoff H, Van Loon K, Matin K, Bullock A, Cronin C, Bagley J, Schrag D The Effect of Disclosing Life Expectancy Information on Patients' Prognostic Understanding: Secondary Outcomes From a Multicenter Randomized Trial of a Palliative Chemotherapy Educational Intervention.  View on PubMed
  14. Enzinger AC, Uno H, McCleary N, Frank E, Sanoff H, Van Loon K, Matin K, Bullock A, Cronin C, Cibotti H, Bagley J, Schrag D Effectiveness of a Multimedia Educational Intervention to Improve Understanding of the Risks and Benefits of Palliative Chemotherapy in Patients With Advanced Cancer: A Randomized Clinical Trial.  View on PubMed
  15. Remes-Troche JM, Hinojosa-Garza G, Espinosa-Tamez P, Meixueiro-Daza A, Grube-Pagola P, Van Loon K, Potter MB, Lajous M Faecal immunochemical test-based colorectal cancer screening in Mexico: an initial experience.  View on PubMed
  16. Manzano-Robleda MDC, Espinosa-Tamez P, Potter MB, Lajous M, Van Loon K, Zhang L, Jimenez-Peña A, Sánchez Del Monte J, Mohar A, Hernández-Guerrero A Fecal Immunologic Test Results and Diagnostic Colonoscopy in a Mexican Population at Average Risk for Colorectal Cancer.  View on PubMed
  17. Unger-Saldaña K, Saldaña-Tellez M, Potter MB, Van Loon K, Allen-Leigh B, Lajous M Barriers and facilitators for colorectal cancer screening in a low-income urban community in Mexico City.  View on PubMed
  18. Susko M, Wang CJ, Lazar AA, Kim S, Laffan A, Feng M, Ko A, Venook AP, Atreya CE, Van Loon K, Anwar M Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients.  View on PubMed
  19. DeBoer RJ, Ndumbalo J, Meena S, Ngoma MT, Mvungi N, Siu S, Selekwa M, Nyagabona SK, Luhar R, Buckle G, Lin TK, Breithaupt L, Kennell-Heiling S, Mushi B, Philipo GS, Mmbaga EJ, Mwaiselage J, Van Loon K Development of a theory-driven implementation strategy for cancer management guidelines in sub-Saharan Africa.  View on PubMed
  20. Ursem C, Zhou M, Paciorek A, Atreya CE, Ko AH, Venook A, Zhang L, Van Loon K Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer.  View on PubMed

Go to UCSF Profiles, powered by CTSI